Add to ORKGIn vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemi
Contains fulltext : 30117_charoflea.pdf (publisher's version ) (Open Access)This t...
Xavier Thomas Hospices Civils de Lyon, Hematology, Lyon-Sud Hospital, Pavillon Marcel Bérard,...
Inhibition of anti-apoptotic BCL-2 has recently emerged as a promising new therapeutic strategy for ...
antileukemic activity in cell lines and primary cultures of acute myeloid leukemi
☯ These authors contributed equally to this work. ‡ These authors also contributed equally to this w...
Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repressio...
Purpose: Although significant progress has been made in the treatment of T-cell acute lymphoblastic ...
TCF3-HLF-positive acute lymphoblastic leukemia (ALL) is currently incurable. Using an integrated app...
Funding Information: The authors would like to acknowledge the patients, study nurses, and other per...
Despite advances in treatment and outcomes for patients with pediatric acute lymphoblastic leukemia ...
Early T-cell precursor-acute lymphoblastic leukemia (ETP-ALL) has been identified as a high-risk sub...
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with ...
Background: Non-Hodgkin’s lymphoma (NHL) comprises a group of related haematological malig-nancies, ...
Stephanie Vairy,* Julia Lopes Garcia,* Pierre Teira, Henrique Bittencourt Division of Haematology a...
Funding Information: The authors would like to thank our colleagues from the Department of Cellular ...
Contains fulltext : 30117_charoflea.pdf (publisher's version ) (Open Access)This t...
Xavier Thomas Hospices Civils de Lyon, Hematology, Lyon-Sud Hospital, Pavillon Marcel Bérard,...
Inhibition of anti-apoptotic BCL-2 has recently emerged as a promising new therapeutic strategy for ...
antileukemic activity in cell lines and primary cultures of acute myeloid leukemi
☯ These authors contributed equally to this work. ‡ These authors also contributed equally to this w...
Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repressio...
Purpose: Although significant progress has been made in the treatment of T-cell acute lymphoblastic ...
TCF3-HLF-positive acute lymphoblastic leukemia (ALL) is currently incurable. Using an integrated app...
Funding Information: The authors would like to acknowledge the patients, study nurses, and other per...
Despite advances in treatment and outcomes for patients with pediatric acute lymphoblastic leukemia ...
Early T-cell precursor-acute lymphoblastic leukemia (ETP-ALL) has been identified as a high-risk sub...
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with ...
Background: Non-Hodgkin’s lymphoma (NHL) comprises a group of related haematological malig-nancies, ...
Stephanie Vairy,* Julia Lopes Garcia,* Pierre Teira, Henrique Bittencourt Division of Haematology a...
Funding Information: The authors would like to thank our colleagues from the Department of Cellular ...
Contains fulltext : 30117_charoflea.pdf (publisher's version ) (Open Access)This t...
Xavier Thomas Hospices Civils de Lyon, Hematology, Lyon-Sud Hospital, Pavillon Marcel Bérard,...
Inhibition of anti-apoptotic BCL-2 has recently emerged as a promising new therapeutic strategy for ...